Andrew Saintsing, PhD
Andrew joined Drug Discovery News as an Intern in 2023. He earned his PhD from the University of California, Berkeley in 2022 and has written for Integrative and Comparative Biology and the Journal of Experimental Biology. As an intern at DDN, he writes about everything from microbes in the digestive tract to anatomical structures in the inner ear. When not writing, Andrew enjoys running and hiking in nature.
Articles by Andrew Saintsing, PhD
| 6 min read
A liver enzyme affects fibrosis progression by altering metabolism of the sugar trehalose in the gut.
| 5 min read
A new method for tracking CAR T cells in patients with blood cancers relies on a probe that binds directly to the therapeutic cells’ antigen receptor.
| 5 min read
The enzyme PGK1 sets the rate of cellular energy production and may be an ideal drug target when Parkinson’s disease neurons struggle to fuel themselves.
| 4 min read
Injecting lung stem cells into the bloodstream of mice with idiopathic pulmonary fibrosis improved their lung function, setting the stage for human trials.
| 9 min read
Ketamine effectively treats depression, but recent studies illustrate the ongoing difficulties in understanding its antidepressant effects at a molecular level.
| 9 min read
A new app relies on smartphone cameras and algorithms to check for signs of neurodivergence in children.
| 4 min read
Zosurabalpin, a macrocyclic peptide, kills drug resistant Acinetobacter baumannii bacteria by blocking cross-membrane transport.
| 3 min read
Inhibiting a single protein may prevent cardiovascular complications in patients with chronic kidney disease.
| 4 min read
A new porcine model for the rare neurological disorder CLN3 Batten disease more faithfully recreates human symptoms and could accelerate drug development.
| 4 min read
Although harmful in large quantities, hydrogen sulfide may ameliorate the health consequences of aging when small doses are applied to the mitochondria.
| 4 min read
Using a machine learning approach, researchers discovered how to make mouse macrophages resistant to tuberculosis infection.
| 3 min read
A small molecule called ALGERNON2 improved health outcomes in mouse models of neurodegenerative diseases by activating antioxidant pathways in astrocytes.
| 4 min read
Selective labeling of cancer stem cells with click chemistry-capable functional groups offers a new strategy for anticancer drug delivery.
| 5 min read
Investigating the neural and molecular pathways that help foragers decide when to look for better resources could lead to new ways to treat mental health conditions.
| 5 min read
An understudied passageway linking the inner ear and the brain in mice offers a potential delivery route for restoring hearing in humans.
Page 1 of 2 - 16 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
